Rwanda: Unveils Neglected Tropical Diseases Strategic Plan 2026-2030

• Rwanda's 2026-2030 NTD Strategic Plan targets the interruption of leprosy and river blindness transmission by 2030.
• The plan estimates 13 million people are at risk of at least one neglected tropical disease, with a focus on rural and underserved communities.
• An estimated Rwf13.79 billion is required for the plan, with Rwanda aiming for 70% domestic funding by 2030.
• Key objectives include submitting WHO validation dossiers for lymphatic filariasis, trachoma, and yaws, and achieving zero human deaths from dog-mediated rabies.
• The strategy involves integrating NTD services into primary healthcare and schools, alongside a shift towards routine deworming for intestinal worms.

By 2030, Rwanda wants zero new locally acquired leprosy cases among children under five for at least five consecutive years, alongside submitting validation dossiers to the World Health Organisation for lymphatic filariasis and trachoma.

Rwanda has unveiled its comprehensive Neglected Tropical Diseases Strategic Plan 2026-2030, a five-year blueprint designed to significantly reduce the burden of neglected tropical diseases (NTDs) across the nation. This ambitious `Rwanda public health strategy` sets a clear objective to interrupt the transmission of both leprosy and onchocerciasis, commonly known as river blindness, by the year 2030. The plan underscores the critical challenge posed by NTDs, estimating that approximately 13 million individuals in Rwanda are currently at risk of contracting at least one such disease, with a particularly severe impact on rural and underserved populations.

Beyond these overarching goals, the strategic plan outlines specific `Rwanda NTD elimination targets` for other prevalent conditions. For instance, the government intends to pilot efforts in selected areas of Bugesera and Ruhango districts to reduce the prevalence of schistosomiasis (bilharzia) and soil-transmitted helminths (intestinal worms) to below one percent. This targeted approach aims to halt transmission in these specific locales, building on previous successes where intestinal worm prevalence notably decreased from 45 percent in 2014 to under 20 percent. The strategy also signals a shift from broad mass drug administration to more routine deworming practices to sustain this progress.

Despite overall progress, leprosy and river blindness continue to pose significant public health challenges in Rwanda. Ongoing transmission of river blindness has been confirmed in focal areas within Rusizi and Nyamasheke districts, which share borders with the Democratic Republic of Congo and Burundi. To address this, Rwanda has developed a distinct national plan for river blindness elimination, aiming for at least 85 percent program coverage annually and achieving 100 percent geographical coverage by 2030.

Leprosy remains endemic in four districts: Gisagara, Bugesera, Ngoma, and Rusizi. Over the last five years, 119 new leprosy cases were reported, with more than 89 percent originating from endemic sectors within these four districts, as well as Nyaruguru. While new leprosy cases have seen a 30 percent decline over the past decade compared to the preceding ten years, the continued detection of new cases among children and individuals presenting with grade-two disabilities indicates persistent transmission and delayed diagnosis. Between July 2019 and June 2025, children accounted for 10.6 percent of 132 new cases, and 16.7 percent exhibited grade-two disability at the commencement of treatment. Proactive contact tracing efforts have reached 537 leprosy household contacts, with 68 percent of those eligible receiving preventive treatment. A key objective of the `Rwanda leprosy river blindness plan` is to achieve zero new locally acquired leprosy cases among children under five for at least five consecutive years by 2030.

The `Rwanda Neglected Tropical Diseases Strategic Plan 2026-2030` extends its focus to several other diseases, aiming for significant milestones in `WHO Rwanda disease eradication` efforts. By 2030, Rwanda plans to submit validation dossiers to the World Health Organisation for lymphatic filariasis (elephantiasis) and trachoma. The country also targets the interruption of yaws transmission, with the goal of submitting documentation to the WHO for verification and achieving WHO eradication certification by 2030. Furthermore, the plan includes an objective to eliminate human deaths from dog-mediated rabies, which will involve vaccinating at least 70 percent of dogs in affected areas annually for a minimum of three consecutive years.

Beyond these specific targets, the strategy incorporates other neglected conditions such as snakebite envenoming, mycetoma, scabies, tungiasis, taeniasis, podoconiosis, and cysticercosis. For these, case detection and clinical care will be integrated into routine health systems, supported by expanded reporting through the national health information system. The estimated cost for implementing this five-year plan is Rwf13.79 billion. A crucial aspect of `Rwanda health sector investment` is the government's aspiration for domestic funding to cover at least 70 percent of the financial requirements for tackling neglected tropical diseases by 2030.

This comprehensive `Rwanda Neglected Tropical Diseases Strategic Plan 2026-2030` signals significant government focus, which could inform legal counsel for clients in the healthcare, pharmaceutical, and development sectors regarding potential future regulatory frameworks, public-private partnership opportunities, or ESG/CSR alignment for operations in Rwanda. The plan's emphasis on integrating NTD services into primary healthcare and schools, alongside the shift towards routine deworming, indicates a strategic evolution in public health service delivery. Such shifts may necessitate new procurement processes, revised compliance standards for medical supplies, or opportunities for technology and infrastructure development in rural health settings.

The substantial financial commitment and the emphasis on domestic funding underscore Rwanda's dedication to this public health initiative, potentially opening avenues for public-private partnership opportunities and signaling areas for ESG/CSR alignment for international entities operating within the country. Understanding these long-term public health priorities and funding commitments is crucial for stakeholders looking to engage with Rwanda's health sector, as they may lead to new policies, procurement needs, or collaborative ventures aligned with the nation's disease eradication goals.

This strategic plan outlines Rwanda's long-term public health priorities and funding commitments, which could inform legal counsel for clients in the healthcare, pharmaceutical, and development sectors regarding potential future regulatory frameworks, public-private partnership opportunities, or ESG/CSR alignment for operations in Rwanda. It signals areas of government focus that may lead to new policies or procurement.

Source: Original reporting via The New Times